Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say
Researchers at the University of Kentucky have found that an experimental Alzheimer's drug, MW150, may help reduce brain inflammation associated with alcohol withdrawal. The drug targets a specific inflammation pathway and has shown promise in laboratory and animal-model studies. This research suggests that MW150 could potentially mitigate the risks of relapse in individuals with alcohol use disorder.
- ▪MW150 is an investigational drug designed to treat mild to moderate Alzheimer's disease.
- ▪The drug was found to reduce inflammatory markers during alcohol withdrawal in laboratory and animal-model experiments.
- ▪Scientists believe that neuroinflammation contributes to relapse risk and long-term neurological damage in people with alcohol use disorder.
Opening excerpt (first ~120 words) tap to expand
Health Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say MW150 was found to reduce inflammatory markers in lab and animal-model experiments By Melissa Rudy Fox News Published May 25, 2026 7:00am EDT Facebook Twitter Threads Flipboard Comments Print Email Add Fox News on Google close Video Jillian Michaels hails ‘fantastic’ trend as American alcohol use hits new low Jillian Michaels joins 'Fox & Friends' to discuss falling U.S. drinking rates and a new study linking walking to fat burning and weight loss. NEWYou can now listen to Fox News articles! An investigational dementia drug may also ease alcohol withdrawal by calming the brain inflammation linked to addiction and relapse.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fox News.
Discussion
0 commentsMore from Fox News
